Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP+-induced cytotoxicity in Parkinson's disease in vitro models.

[1]  B. Hyman,et al.  Small Heat Shock Proteins Protect Against α-Synuclein-Induced Toxicity and Aggregation , 2006 .

[2]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[3]  J. Parvin,et al.  Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. , 2006, Human molecular genetics.

[4]  W. Springer,et al.  Mechanisms and models of α-synuclein-related neurodegeneration , 2006 .

[5]  R. Abagyan,et al.  Discovery of bioactive small-molecule inhibitor of poly adp-ribose polymerase: implications for energy-deficient cells. , 2006, Chemistry & biology.

[6]  V. Schreiber,et al.  Poly(ADP-ribose): novel functions for an old molecule , 2006, Nature Reviews Molecular Cell Biology.

[7]  K. Maiese,et al.  Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide. , 2006, Current medicinal chemistry.

[8]  C. Szabó.  Poly(ADP-ribose) polymerase activation by reactive nitrogen species--relevance for the pathogenesis of inflammation. , 2006, Nitric oxide : biology and chemistry.

[9]  V. Dawson.  Inhibition of poly(adenosine diphosphate-ribose) polymerase (PARP) in experimental models of neurologic diseases: cell death prevention. , 2005, Retina.

[10]  T. Dawson,et al.  Mediation of cell death by poly(ADP-ribose) polymerase-1. , 2005, Pharmacological research.

[11]  L. Virág.  Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. , 2005, Current vascular pharmacology.

[12]  Csaba Szabó,et al.  Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors , 2005, Nature Reviews Drug Discovery.

[13]  E. Petermann,et al.  Importance of poly(ADP-ribose) polymerases in the regulation of DNA-dependent processes. , 2005, Cellular and molecular life sciences : CMLS.

[14]  T. Dawson,et al.  Poly(ADP-ribosyl)ation regulation of life and death in the nervous system. , 2005, Cellular and molecular life sciences : CMLS.

[15]  C. Szabó,et al.  Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. , 2005, Cellular and molecular life sciences : CMLS.

[16]  Andrew J Duncan,et al.  Nitric oxide and neurological disorders. , 2005, Molecular aspects of medicine.

[17]  B. Hyman,et al.  Geldanamycin induces Hsp70 and prevents α-synuclein aggregation and toxicity in vitro , 2004 .

[18]  T. Dawson,et al.  Deadly Conversations: Nuclear-Mitochondrial Cross-Talk , 2004, Journal of bioenergetics and biomembranes.

[19]  G. de Murcia,et al.  The PARP superfamily , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  M. Vila,et al.  Genetic clues to the pathogenesis of Parkinson's disease , 2004, Nature Medicine.

[21]  Jochen Klucken,et al.  Hsp70 Reduces α-Synuclein Aggregation and Toxicity* , 2004, Journal of Biological Chemistry.

[22]  A. Iwashita,et al.  Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson's Disease , 2004, Journal of Pharmacology and Experimental Therapeutics.

[23]  S. Lindquist,et al.  Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.

[24]  K. Heidenreich,et al.  The pesticide rotenone induces caspase‐3‐mediated apoptosis in ventral mesencephalic dopaminergic neurons , 2003, Journal of neurochemistry.

[25]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[26]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[27]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[28]  M. Vila,et al.  The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model , 2003 .

[29]  T. Dawson,et al.  Apoptosis Inducing Factor and PARP‐Mediated Injury in the MPTP Mouse Model of Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[30]  Nutan Sharma,et al.  TorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregation , 2002, Journal of neurochemistry.

[31]  Robert Burke,et al.  Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Lumpkin,et al.  A novel in vivo post‐translational modification of p53 by PARP‐1 in MPTP‐induced parkinsonism , 2002, Journal of neurochemistry.

[33]  Ted M. Dawson,et al.  Animal Models of PD Pieces of the Same Puzzle? , 2002, Neuron.

[34]  J. Yun,et al.  Protective effect of L-carnosine against 12-O-tetradecanoylphorbol-13-acetate- or hydrogen peroxide-induced apoptosis on v-myc transformed rat liver epithelial cells. , 2002, Cancer letters.

[35]  B. Hyman,et al.  α-Synuclein–enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons , 2001, Neuroscience.

[36]  C. Cosi,et al.  Implication of Poly(ADP‐Ribose) Polymerase (PARP) in Neurodegeneration and Brain Energy Metabolism: Decreases in Mouse Brain NAD+ and ATP Caused by MPTP Are Prevented by the PARP Inhibitor Benzamide , 1999, Annals of the New York Academy of Sciences.

[37]  D. Guastella,et al.  Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Masliah,et al.  Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[39]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[40]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[41]  E. Masliah,et al.  Neurofibrillary tangles in the dentate granule cells of patients with Alzheimer’s disease, Lewy body disease and progressive supranuclear palsy , 1996, Acta Neuropathologica.